Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion type Assertion NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_head.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion description "[Recent studies support the following conclusions: first, oral contraceptive use reduces ovarian cancer risk without significantly increasing breast cancer risk, second, salpingo-oophorectomy leads to a reduction in ovarian cancer, breast cancer, and overall mortality for women who are carriers of BRCA1 and BRCA2 mutations, and third, the 'ovarian cancers' associated with BRCA mutations actually include fallopian tube and peritoneal cancer and may have a precursor lesion in the fallopian tube; this observation has prompted the provocative suggestion of removing the fallopian tube to reduce ovarian cancer risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_provenance.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion evidence source_evidence_literature NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_provenance.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion SIO_000772 25490378 NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_provenance.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion wasDerivedFrom befree-2016 NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_provenance.
- NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_assertion wasGeneratedBy ECO_0000203 NP1246444.RAuouRl-SC1FDyeVj_5QVJ01Rdy94wZT6Ew0ZX7dSbv-s130_provenance.